16:01 Dec 26
Beryl Drugs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Beryl Drugs Ltd.
Industry Pharmaceuticals
16:01 Dec 26
Quality
0/100
Not Eligible
Valuation
45/100
Mid Valuation
Technical
63/100
Technically Moderately Bullish
Strength
6
Weakness
8
Opportunity
0
Threats
0
8.61 %
ROE %
0.00 %
ROA %
0.00
EPS
0.00
BVPS
6.21 %
Net Profit Margin
| Mar 2017 | Mar 2018 | ||
|---|---|---|---|
| Net Sales | 11.53 | 15.99 | |
| Operating Expenses + | 11.31 | 14.3 | |
| Raw Material | 6.94 | 8.91 | |
| Increase Decrease in Cost | -0.45 | 0.45 | |
| Other Manufacturing Expense | 0 | 0 | |
| Employee Cost | 0.98 | 0.73 | |
| Miscellaneous Expenses | 3.84 | 4.21 | |
| Operating Profit | 0.22 | 1.69 | |
| Other Income | 0 | 0 | |
| Depreciation | 0.38 | 0.33 | |
| Interest | 0.2 | 0.13 | |
| Profit before tax and exceptio.. | -0.36 | 1.23 | |
| Exceptional Items | 0 | 0 | |
| PBT | -0.36 | 1.23 | |
| Provision for Taxation | 0.05 | 0.23 | |
| Net Profit | -0.41 | 0.99 | |
| NET Profit after MI | -0.41 | 0.99 | |
| EPS | 0 | 1.96 | |
| Operating Profit Margin (%) | 1.91 | 10.57 | |
| Net Profit Margin (%) | -3.56 | 6.19 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
|---|---|---|---|---|---|
| Promoter | 26.40 | 26.40 | 26.40 | 26.40 | 26.40 |
| FII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| MF | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 73.60 | 73.60 | 73.60 | 73.60 | 73.60 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
